In April 2011, Neugenesis Corporation was acquired by Intrexon Corporation, a next generation synthetic biology company. Neugenesis has developed recombinant technologies and production systems related to Neurospora crassa, an exceptionally versatile fungal organism capable of producing a wide spectrum of proteins and metabolites of commercial interest. the firm had been working on development of combinatorial biology technologies such as protein production systems to create libraries for the discovery and improvement of biotherapeutics. Proteins included monomeric, homodimeric and heteromeric proteins. This technology mimics the immune system's ability to generate diversity in antibodies and expands this ability to all heteromeric proteins, not just antibodies. Intrexon also announced that the former Neugenesis facility would become the headquarters for IntrexonÂ’s Industrial Products Division.
